After Nebius shares surged, the company enters the Q1 earnings window; Morgan Stanley maintains Equal-weight and sees near-term risk/reward as skewed negative
AI summary card
After Nebius shares surged, the company enters the Q1 earnings window; Morgan Stanley maintains Equal-weight and sees near-term risk/reward as skewed negative
The report recognizes Nebius' progress in AI cloud demand, the large Meta deal, NVIDIA partnership, financing, and power reserves, but believes the current share price already reflects elevated expectations; going forward, the stock is more likely to continue performing only if the company delivers, raises guidance, and clarifies NJ site risks.
- NBIS shares have risen more than 100% over the past three months, with the current price around $176.42, above Morgan Stanley's $126 price target; the report views near-term risk/reward as skewed negative.
- Industry AI infrastructure demand and GPU pricing remain strong; Nebius' roughly $550MM of ARR outside Microsoft and Meta includes spot or shorter-term contracts that may benefit from higher pricing.
- The company announced a $27B Meta agreement, a strategic partnership with NVIDIA, a $2B prepaid warrant investment, and $4.3B convertible debt financing, strengthening its ability to fund infrastructure expansion in 2026.
- The key uncertainty is the delivery of the remaining Microsoft batches and potential delays at the Vineland, NJ site; if some deployments are pushed into FY27, 2026 revenue could be materially affected.
- Investors are focused on whether Q1 brings higher revenue and margin guidance, a reaffirmation of the $7-$9B ARR target, disclosure of power progress, and greater transparency on orders/backlog.
Report interpretation
Overview
This is a Q1 earnings preview for Nebius Group NV. Morgan Stanley believes the company's fundamental news flow during Q1 was relatively strong, including the $27B Meta agreement, NVIDIA partnership, capital replenishment, strong GPU pricing trends, and on-time completion of the second Microsoft delivery batch. However, because the share price has risen more than 100% within three months, market requirements for delivery, guidance, and power expansion have clearly increased. The report maintains Equal-weight and believes the risk/reward around the current $176 level is skewed negative in the near term.
Core views
The core view is that Nebius has differentiated AI cloud and Neocloud assets and is a long-term beneficiary of undersupply in AI compute, repricing of spot and short-term contracts, customer diversification, and improved financing capacity; however, in the near term, the share price requires the company to meet several high bars at the same time, including confirming that Microsoft deployments are proceeding as planned, raising full-year revenue and margin guidance, proving that high GPU prices are translating into benefits, increasing power targets, and reaffirming the $7-$9B ARR target. The report believes these requirements are not impossible, but at the current valuation and share price level, any performance below elevated expectations could trigger downside.
Analysis framework
The report analyzes NBIS using an earnings-preview and risk/reward framework, focusing on demand, supply/power, orders and RPO, financing, guidance, valuation, and scenario returns. Valuation uses forward free cash flow multiples and long-term revenue and margin assumptions, combined with the current share price, price target, bull/bear scenarios, and peer comparison with CoreWeave to assess near-term allocation attractiveness.
Methodology notes
Enterprise value multiple valuation based on 2035 free cash flow
The NBIS price target corresponds to approximately 21x EV/CY35 FCF, based on $5.4B CY35 FCF, and implies approximately 10x EV/CY27 EBITDA; the bull-case scenario is $233, the base-case range is approximately $67-$165, and the bear-case scenario is $22.
Bull-case, base-case, and bear-case price scenarios
The report compares the current price of $176.42 with the $126 price target and scenario prices, concluding that upside from the current price is limited while downside scenarios are significant.
Comparison of Morgan Stanley forecasts with consensus expectations
The report cites Refinitiv consensus and Morgan Stanley models to compare 1Q26, FY26, and FY27 revenue, operating margin, capital expenditure, and free cash flow.
Asset mapping & comparison
Structured mapping from thesis to named assets (strengths, weaknesses, peers, risks).
- Nebius Group NV (NBIS.O / US.NBIS)Core covered company
- Strengths
- Differentiated vertically integrated AI cloud, strong external validation, large Meta and Microsoft customers, NVIDIA partnership, improved financing capacity, progress on power and data center projects, and potential repricing of spot and short-term contracts.
- Weaknesses
- Profitability and long-term execution track record remain insufficiently validated; near-term targets are aggressive and require substantial new orders and capacity delivery support.
- Comparison
- Compared with CoreWeave, Nebius has greater optionality from more diversified customers, funding sources, and data center strategy, while CoreWeave stands out more in scale leadership and visibility.
- Risks
- Delays at the Vineland, NJ site, delays in Microsoft batch deliveries, 2026 revenue pushed into FY27, normalization of AI demand, customers building their own compute, rising financing costs, and competitive and regulatory pressure.
- CoreWeave Inc (CRWV.O / US.CRWV)Peer comparison and tactically preferred company
- Strengths
- Scale leadership, with stronger momentum and visibility in a supply-constrained environment.
- Weaknesses
- Customer concentration and long-term GPU monetization assumptions still need to be validated.
- Comparison
- The report explicitly states that, in the current event window, it tactically prefers CRWV rather than NBIS after its substantial rally.
- Risks
- Large customers building their own AI compute, shorter useful life of AI servers, financing costs, and capital market availability.
- Meta Platforms Inc (META.US)Major Nebius customer and source of demand validation
- Strengths
- The $27B agreement enhances Nebius' demand visibility, with part of the arrangement supporting Nebius in selling capacity to a broader set of enterprise customers.
- Weaknesses
- If demand or procurement plans from large customers change, Nebius' capacity utilization and revenue path could be affected.
- Comparison
- The Meta agreement and Microsoft contract together constitute the core evidence of Nebius' external validation.
- Risks
- Customer concentration, changes in procurement cadence, and uncertainty over the economics of unused capacity arrangements.
- NVIDIAStrategic partner and investor
- Strengths
- NVIDIA announced a deepening partnership with Nebius in AI factory infrastructure, production software, and the AI technology stack, and invested $2B.
- Weaknesses
- The value of the partnership still depends on Nebius' execution in construction, supply, deployment, and commercialization.
- Comparison
- The NVIDIA partnership strengthens Nebius' position in the AI infrastructure ecosystem.
- Risks
- Supply chain, GPU availability, system deployment cadence, and capital expenditure pressure.
- MicrosoftCore contract customer
- Strengths
- The $17.4B contract and on-time second batch delivery provide positive signals on execution capability.
- Weaknesses
- Most batches are expected in the second half, and the market remains concerned about delays related to the Vineland, NJ site.
- Comparison
- The Microsoft contract is a key support for Nebius' 2026 revenue and ARR path.
- Risks
- Delays in the remaining batches could push revenue from FY26 to FY27, materially affecting 2026 financial performance.
Key data
- RatingEqual-weightThe report maintains a neutral relative rating.
- Price target$126.00The current price of $176.42 corresponds to an implied return of approximately -28.6%.
- Current share price$176.42Closing price as of 2026-05-04.
- Market capitalization$44,637MMCurrent market capitalization disclosed in the report table.
- 52-week range$179.40-$23.25The share price is close to its 52-week high.
- Meta agreement$27BThe $15B portion allows Nebius to build and sell capacity to a broader set of enterprise customers, with Meta committed to purchasing unused capacity.
- Microsoft contract$17.4BThe second delivery batch has been completed on time, but the remaining batches and progress at the NJ site are key risks.
- RPO$21.3B; pro forma including the $27B Meta transaction could exceed $45BDisclosed in the latest 20-F; quarterly RPO or backlog disclosure remains limited.
- Microsoft prepayment$7BApproximately 40% of the total contract value, strengthening funding capacity for construction in 2026.
- NVIDIA investment$2BInvestment through prepaid share purchase warrants, enabling the purchase of approximately 21M Class A shares.
- Convertible debt financing$4.3BIncludes $2.5875B of 1.25% notes due 2031 and $1.75B of 2.625% notes due 2033.
- 2026 revenue forecast$3,299.2MM MS vs. $3,282.7MM Cons.Morgan Stanley is broadly in line with consensus.
- 2027 revenue forecast$9,385.2MM MS vs. $9,745.9MM Cons.Morgan Stanley is below consensus.
- 2026 capital expenditure forecast$19,873.0MM MS vs. $15,584.6MM Cons.Morgan Stanley forecasts capital expenditure significantly above consensus.
- Expected 2028 exit ARR~$13BBased on demand and execution of capacity ramp-up.
- Job posting trendApproximately increased from 55 in December 2024 to 325 in April 2026The chart shows a significant rise in hiring demand; figures are visual estimates.
Impact & implications
In terms of investment implications, NBIS remains a long-term beneficiary of tight supply/demand in AI compute infrastructure, but the current share price has already fully reflected positives from Meta, NVIDIA, financing, and GPU pricing. Near-term catalysts are concentrated on the Q1 earnings call: if management cannot clearly confirm the Microsoft delivery schedule, NJ site risk, upward revisions to full-year revenue/margins, and the path to $7-$9B ARR, the share price may come under pressure. Relatively speaking, Morgan Stanley tactically prefers the setup in CRWV.
Risks
- After the share price rose more than 100% over three months, market expectations are too high, and even a slight shortfall in results or guidance could lead to valuation compression.
- The Vineland, NJ site may face risks from local hearings, protests, or construction delays, and management needs to clarify the actual impact on the earnings call.
- If the remaining seven Microsoft batches cannot be delivered as planned, 2026 revenue and the ARR path could be materially affected.
- The AI demand environment may normalize, and GPU prices and returns may come under pressure.
- Large customers may shift more AI compute to self-builds in the future, weakening external Neocloud demand.
- Rising financing costs or reduced capital market availability could affect large-scale data center construction.
- Competitive, macro, and regulatory dynamics could compress pricing, margins, and growth visibility.
- Profitability and long-term free cash flow still depend on longer-dated assumptions, and the execution track record has not yet been fully validated.
What to watch
- Whether management confirms in Q1 results that Microsoft delivery remains on schedule.
- Whether the Vineland, NJ site has substantive delays and whether they affect specific contract batches.
- Whether full-year 2026 revenue guidance is raised and comes in above consensus.
- Whether margin guidance or commentary improves and supports the medium-term 20%-30% EBIT margin target.
- Whether the company reaffirms the $7-$9B ARR target and provides more transparency on orders, RPO, or backlog.
- The cadence of newly contracted power, connected power, and active power delivery.
- Whether GPU spot and short-term contract repricing can translate into higher revenue and margins.
- Whether capital expenditure is reaffirmed or raised, and whether funding sources are sufficient to cover 2026 expansion.
- Whether hiring, customer contracts, software products, and major-customer expansion continue to support long-term growth.